Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OR52L2P, or Olfactory receptor family 52 subfamily L member 2 pseudogene, is annotated as a **pseudogene** within the human genome and is part of the large family of olfactory receptors, which are typically G protein-coupled receptors (GPCRs) with a seven transmembrane domain structure[3]. While canonical olfactory receptors detect odorant molecules and mediate the sense of smell via G protein-transduced signaling, pseudogenes such as OR52L2P are considered non-functional and are not known to translate into active proteins[3]. There is no evidence supporting a therapeutic or disease-related role, nor association with any drugs, biomarkers, or clinical safety concerns. Its sequence similarity to olfactory receptors reflects a likely ancestral function in olfaction, but current data do not support its role as a functional or druggable protein target in humans[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 52 subfamily L member 2 pseudogene (OR52L2P).